Hepatitis C News

Another study has highlighted the potential for physicians to concurrently treat certain infections and substance use disorders.

I never had any intention of pursuing a career in infectious diseases — or medicine for that matter.

The HCV-Seek Test and Rapid Treatment model achieved significantly higher cure rates compared with usual care among young people who inject drugs, according to data presented at IDWeek.

IDWeek, originally planned for San Diego, will be an all-virtual meeting for the second year in a row because of COVID-19.

I began my training at the beginning of the HIV pandemic. I still remember a lecture during my second year of medical school in which a young man told us that his friends were dying of a new disease called gay-related immunodeficiency disease, subsequently known as AIDS.

In the wake of the COVID-19 pandemic, data indicate that there has been a surge in interest among U.S. college students in pursuing medicine as a career.

Because of pandemic-related disruptions in hepatitis C care, researchers said thousands of cases will remain unidentified with fewer patients initiating care and achieving SVR.

The COVID-19 pandemic has further disrupted WHO’s global hepatitis elimination strategy, which aims to reduce new cases of chronic HBV and HCV infection by 90% and reduce deaths from the infections by 65% by 2030.

I chose ID as a medical specialty because of the intellectual stimulation and investigative nature that accompanies the study of microbes within humans.

In May, WHO released a 112-page progress report that detailed gaps in the efforts to eliminate HIV, hepatitis and STIs by 2030.